Transaction · 0002147232-26-000006

FORTUNATO MICHAEL A

FORTUNATO MICHAEL A, CAO, reported a transaction classified as exercise at BioStem Technologies, Inc. involving 970.000000 shares for an estimated $0.00. Reported holdings after the transaction were 6790.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

exerciseSEC transaction code MCAO
BSEMBioStem Technologies, Inc.
Filing timeAug 20
Trade dateAug 09, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$3.68
Pre-filing
1mo ago1w ago1d ago +11.1%
Returns since
7d +4.6%30d -4.9%90d -4.9%180d -4.9%1y -4.9%

BSEM price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
BSEM since 2026-08-20Filed 15 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
exercise
Code M
Identifier
0002147232-26-000006
Restricted Stock Units
Transaction date
Aug 09, 2026
Filed Aug 20, 2026, 11:30 PM · 11d delay
Shares
970 sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
6.79k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 11 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Derivative Transaction Direct Ownership
-16score
Filing-only score

-16

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Accounting Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    These options are fully vested and exercisable.

  2. F2

    These options vest according to the following schedule: 25% vested on January 4, 2024, with the remaining options vesting in equal monthly installments over the subsequent three year period.

  3. F3

    These options vest with the following schedule: 33% vested on May 9, 2026, with the remaining options vesting in equal quarterly installment over the subsequent two year period.

  4. F4

    These option vest with the following schedule: 33% will vest on October 13, 2026, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over th…

  5. F5

    These options vest with the following schedule: 33% will vest on February 11, 2027, the one year anniversary of the grant date, with the remaining options vesting in equal quarterly installments over…

  6. F6

    Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

  7. F7

    These restricted stock units vest in equal quarterly installments over three years from the grant date (September 15, 2024).

  8. F8

    These restricted stock units vest according to the following schedule: 33% vested on May 9, 2026, with the remaining units vesting in equal quarterly installments over the subsequent two year period.…

  9. F9

    These restricted stock units vest according to the following schedule: 33% vest on February 11, 2027, the one year anniversary of the grant date, with the remaining units vesting in equal quarterly in…

Original filing · 0002147232-26-000006
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

BSEM